Kirill Nemirov

Institut Pasteur — France

Medicine · Health Sciences

22h-index1.3kcitations39works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Vectors(26), Fire effects on ecosystems(17), Viral Infections and Outbreaks Research(15), SARS-CoV-2 and COVID-19 Research(11), COVID-19 Clinical Research Studies(5)

Publications39 total

Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses
Vaccine·2025Open Access
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy
Scientific Reports·2025Open Access
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
Frontiers in Immunology·2023· 5 citedOpen Access
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication
Microbes and Infection·2023· 4 citedOpen Access
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
Pharmaceutics·2023· 24 citedOpen Access
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Vaccines·2022· 3 citedOpen Access
Mice Humanized for Major Histocompatibility Complex and Angiotensin-Converting Enzyme 2 with High Permissiveness to SARS-CoV-2 Omicron Replication
2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Molecular Therapy·2022· 26 citedOpen Access
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
2022Open Access
Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
EMBO Molecular Medicine·2021· 33 citedOpen Access
Brain and Lung Cross-Protection against Ancestral or Emerging SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Murine Model
Research Square (Research Square)·2021Open Access
Full Brain and Lung Prophylaxis against SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Mouse Model or Golden Hamsters
2021· 3 cited
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Cell Host & Microbe·2020· 141 citedOpen Access
Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models
2020· 6 cited
Analysis of Dobrava hantavirus isolate from Greece: comparison with less pathogenic Saaremaa virus and evidence for a host switch in evolution of European hantaviruses carried by Apodemus mice
Jukuri (Natural Resources Institute Finland (Luke))·2015
Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
Cell Reports·2014· 88 citedOpen Access
Novel Hantavirus strains in Apodemus-mice in Estonia and Latvia
Jukuri (Natural Resources Institute Finland (Luke))·2013
Conserved Proline-Rich Region of Ebola Virus Matrix Protein VP40 Is Essential for Plasma Membrane Targeting and Virus-Like Particle Release
The Journal of Infectious Diseases·2011· 28 citedOpen Access
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs
The Journal of Infectious Diseases·2011· 79 citedOpen Access
Characterization of Two Substrains of Puumala Virus That Show Phenotypes That Are Different from Each Other and from the Original Strain
Journal of Virology·2010· 23 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Alexander Plyusnin(18), Pierre Charneau(14), Maryline Bourgine(13), Pierre Authié(13), Amandine Noirat(13), Laleh Majlessi(13), Åke Lundkvist(12), Antti Vaheri(11), Benjamin Vesin(11), François Anna(11), Heikki Henttonen(10), Fanny Moncoq(10), Françoise Guinet(10), Angelina Plyusnina(9), Catherine Blanc(9), David Hardy(9), Ingrid Fert(8), Olli Vapalahti(7), Jodie Lopez(7), Philippe Souque(7)